The first reported case of an inherited pathogenic CHD2 variant in a clinically affected mother and daughter
Pathogenic variants in CHD2 (chromodomain helicase DNA‐binding protein 2) have been reported in neurodevelopmental disorders with a broad spectrum of phenotypic variability, ranging from mild intellectual disability to atonic‐myoclonic epilepsy. However, given the paucity of reported cases the exten...
Saved in:
Published in | American journal of medical genetics. Part A Vol. 176; no. 7; pp. 1667 - 1669 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wiley Subscription Services, Inc
01.07.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pathogenic variants in CHD2 (chromodomain helicase DNA‐binding protein 2) have been reported in neurodevelopmental disorders with a broad spectrum of phenotypic variability, ranging from mild intellectual disability to atonic‐myoclonic epilepsy. However, given the paucity of reported cases the extent of this phenotypic spectrum is currently unknown. Furthermore, all confirmed pathogenic CHD2 variants reported to date have been de novo, preventing the study of intrafamilial phenotypic heterogeneity and creating ambiguity regarding recurrence risk, penetrance, and expressivity. Here, we report the first known case of an inherited pathogenic CHD2 variant in affected mother and daughter. This case demonstrates intrafamilial phenotypic heterogeneity and confirms potential heritability of CHD2‐related neurodevelopmental disorders. |
---|---|
Bibliography: | Funding information Ruth L. Kirschstein Institutional National Research Service Award, Grant/Award Number: T32 GM007526‐39 ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
ISSN: | 1552-4825 1552-4833 |
DOI: | 10.1002/ajmg.a.38835 |